Register to chat with like-minded investors on our interactive forums.

Get Started

IVA

Inventiva (IVA)

Inventiva

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:IVA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Date	Time	Source	Headline	Symbol	Company
03/04/2021	4:00PM	GlobeNewswire Inc.	2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United St...	EU:IVA	Inventiva
02/25/2021	4:00PM	GlobeNewswire Inc.	Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to ...	EU:IVA	Inventiva
02/25/2021	4:00PM	GlobeNewswire Inc.	Inventiva annonce une collaboration pour développer des biomarqueurs non-invasifs permettant l’identification de patients ...	EU:IVA	Inventiva
02/25/2021	4:00PM	GlobeNewswire Inc.	Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to ...	EU:IVA	Inventiva
02/24/2021	4:00PM	GlobeNewswire Inc.	Inventiva to participate at several investor conferences in March 2021	EU:IVA	Inventiva
02/24/2021	4:00PM	GlobeNewswire Inc.	Inventiva participera à plusieurs conférences investisseurs en mars 2021	EU:IVA	Inventiva
02/23/2021	4:00PM	GlobeNewswire Inc.	Inventiva’s 2020 Full-Year Financial Results Presentation	EU:IVA	Inventiva
02/23/2021	4:00PM	GlobeNewswire Inc.	Présentation des résultats financiers 2020 d’Inventiva	EU:IVA	Inventiva
02/11/2021	4:00PM	GlobeNewswire Inc.	Full-Year 2020: Cash position and revenues	EU:IVA	Inventiva
02/11/2021	4:00PM	GlobeNewswire Inc.	Exercice 2020 : Position de trésorerie et chiffre d’affaires	EU:IVA	Inventiva
02/11/2021	4:00PM	GlobeNewswire Inc.	Full-Year 2020: Cash position and revenues	EU:IVA	Inventiva
01/15/2021	11:45AM	GlobeNewswire Inc.	Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux	EU:IVA	Inventiva
01/15/2021	11:45AM	GlobeNewswire Inc.	Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux	EU:IVA	Inventiva
01/06/2021	4:00PM	GlobeNewswire Inc.	Inventiva annonce sa participation à la « 39th Annual J.P. Morgan Healthcare Conference »	EU:IVA	Inventiva
01/06/2021	4:00PM	GlobeNewswire Inc.	Inventiva annonce sa participation à la « 39th Annual J.P. Morgan Healthcare Conference »	EU:IVA	Inventiva
01/05/2021	4:00PM	GlobeNewswire Inc.	Inventiva announces design of Phase III clinical trial with lanifibranor in NASH	EU:IVA	Inventiva
01/05/2021	4:00PM	GlobeNewswire Inc.	Inventiva annonce le design de son étude clinique de Phase III avec lanifibranor dans la NASH	EU:IVA	Inventiva
01/05/2021	4:00PM	GlobeNewswire Inc.	Inventiva announces design of Phase III clinical trial with lanifibranor in NASH	EU:IVA	Inventiva
12/07/2020	4:00PM	GlobeNewswire Inc.	Inventiva announces the publication in the Journal of Hepatology of new pre-clinical data showing the beneficial effects of l...	EU:IVA	Inventiva
12/07/2020	4:00PM	GlobeNewswire Inc.	Inventiva annonce la publication dans la revue « Journal of Hepatology » de nouvelles données pré-cliniques démontrant...	EU:IVA	Inventiva
12/07/2020	4:00PM	GlobeNewswire Inc.	Inventiva announces the publication in the Journal of Hepatology of new pre-clinical data showing the beneficial effects of l...	EU:IVA	Inventiva
11/24/2020	4:00PM	GlobeNewswire Inc.	Inventiva annonce sa participation à la « Piper Sandler 32nd Annual Virtual Healthcare Conference »	EU:IVA	Inventiva
11/24/2020	4:00PM	GlobeNewswire Inc.	Inventiva to participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference	EU:IVA	Inventiva
11/12/2020	4:00PM	GlobeNewswire Inc.	Information financière du 3ème trimestre 2020	EU:IVA	Inventiva
11/12/2020	4:00PM	GlobeNewswire Inc.	Q3 2020 Financial Information	EU:IVA	Inventiva
11/12/2020	4:00PM	GlobeNewswire Inc.	Q3 2020 Financial Information	EU:IVA	Inventiva
11/10/2020	4:00PM	GlobeNewswire Inc.	Inventiva receives positive FDA feedback to advance its lead drug candidate lanifibranor into pivotal Phase III in NASH	EU:IVA	Inventiva
11/10/2020	4:00PM	GlobeNewswire Inc.	Inventiva receives positive FDA feedback to advance its lead drug candidate lanifibranor into pivotal Phase III in NASH	EU:IVA	Inventiva
11/10/2020	4:00PM	GlobeNewswire Inc.	Inventiva reçoit un retour positif de la FDA pour démarrer la Phase III pivot dans la NASH avec lanifibranor, son principal...	EU:IVA	Inventiva
11/09/2020	4:00PM	GlobeNewswire Inc.	Inventiva annonce sa participation à la « Stifel Virtual Healthcare Conference 2020 » et la « 11th Jefferies Virtual Heal...	EU:IVA	Inventiva

Showing the most relevant articles for your search:EU:IVA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next >>

Seafarer Exploration (PK)

Maxeon Solar Technologies

Ronn Motor (PK)

Impact Fusion (PK)

Kraig Biocraft Laborator... (QB)

Rennova Health (PK)

Net Savings Link (PK)

Decentral Life (PK)

Northwest Biotherapeutics (QB)

ERHC Energy (CE)

NioCorp Developments

Delayed Upgrade Clock